Sanofi renamed Synovia after acquisition by Beximco

Beximco Pharmaceuticals has changed the name of its recently acquired subsidiary Sanofi Bangladesh to Synovia Pharma Plc, reports bdnews24.com.

Sanofi Bangladesh was part of the global biopharmaceutical company Sanofi SA before the acquisition of a majority stake, 54.6 percent, in the company by Beximco Pharma on Oct 1, 2021.

The change of the name has been made in compliance with the terms of the share purchase agreement between the company and the sellers, Beximco Pharma said in a filing to the London Stock Exchange on Friday.

The name Synovia is derived from the French word Synergie, meaning "collaboration" and the Latin word Via, meaning "path", according to the filing.

"Synovia Pharma will continue to manufacture, market and import Sanofi SA products, ensuring continued supply for patients in Bangladesh across therapeutic areas such as cardiology, diabetes, oncology, dermatology and CNS," Beximco said.